Skip to main content
. 2010 Jul 23;2(4):402–411.

Table 3.

BR-DIM PK parameters after the oral administration of the first dose of BR-DIM on Cycle 1, Day 1

Patient # Dose (mg) Tmax (h) Cmax (ng/ml) AUC0-t (ng/ml h) Mean Cmax (CV%) (ng/mL) Mean AUC0-t (CV%) (ng/mL*h)
1 75 3.0 57 224 42 (32%) 192(16%)
2 75 4.0 34 189
3 75 3.0 34 163
4* 150 3.0 139 638 104(29%) 450 (43%)
5* 150 3.0 87 251
6 150 4.0 87 462
7 225 4.0 241 1231 134 (59%) 599 (70%)
4* 225 4.0 54 374
5* 225 2.0 106 370
8 225 4.0 135 423
9 300 3.0 452 1472 236 (66%) 899 (48%)
10 300 2.0 138 578
11 300 2.0 244 984
12 300 3.0 112 563
*

Patients with intra-patient dose escalation.

Patient ID numbers in Table 3 match those in Figure 2, for the subset of 7 patients shown in Figure 2.